Trials / Completed
CompletedNCT07019584
"Wai Ji Match Fun" Card Games for People With Intellectual Disabilities
Feasibility, Acceptability and Benefits of "Wai Ji Match Fun" Card Games on Cognitive Performance and Psychosocial Wellbeing for People With Intellectual Disabilities
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A new set of card game, Wai Ji Match Fun (WJMF), has been developed by Wai Ji Christian Service (WJCS), a non-governmental organization in Hong Kong, specifically designed for individuals with intellectual disabilities (ID). The game aims to enhance cognitive performance and psychosocial well-being while facilitating daily participation.
Detailed description
This study evaluates the feasibility and acceptability of WJMF for individuals with ID, and its immediate and carry-over impacts on psychosocial well-being and cognitive function. Sixty-four adult participants with mild to moderate ID were recruited for the study. Each participant attends a weekly 60-minute WJMF group program over an 8-week period. Groups of four participants are facilitated by occupational therapists or rehabilitation assistants. Outcome measures include the Personal Wellbeing Index - Intellectual Disability (PWI-ID) (Chinese-Cantonese version), the short version of the Prudhoe Cognitive Function Test (PCFT), attendance rates, and staff feedback on feasibility and acceptability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Wai Ji Match Fun card games | Group intervention using game activities with Wai Ji Match Fun cards. A total of eight group sessions, which last for 60 minutes each, will be conducted once a week for a period of 8 weeks. |
Timeline
- Start date
- 2024-07-11
- Primary completion
- 2025-08-31
- Completion
- 2025-10-31
- First posted
- 2025-06-13
- Last updated
- 2025-12-01
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT07019584. Inclusion in this directory is not an endorsement.